DE:OS1 Stock Latest News
Company AnnouncementsOtsuka Holdings to Shift Governance Structure to Audit and Supervisory Committee Model2d ago
Company AnnouncementsOtsuka Holdings Completes ¥50 Billion Share Buyback and Plans Cancellation of Treasury Shares2d ago
Company AnnouncementsOtsuka Lifts Nine-Month Profits, Ups Dividend and EPS Outlook on Share Buybacks2d ago
Pre-EarningsOTSKF Earnings Report this Week: Is It a Buy, Ahead of Earnings?4d ago
Company AnnouncementsOtsuka’s VOYXACT Delivers Landmark Phase 3 Results in IgA Nephropathy1w ago
Company AnnouncementsOtsuka Seeks Full U.S. Approval for IgA Nephropathy Drug VOYXACT3w agoCompany AnnouncementsOtsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR1M ago
Company AnnouncementsOtsuka’s Zipalertinib Combo Delivers Strong Phase 3 Lung Cancer Results1M ago
Company AnnouncementsOtsuka Holdings Advances ¥50 Billion Share Buyback Program2M ago- Company AnnouncementsOtsuka’s Zipalertinib Combo Hits Phase 3 Goal in Targeted Lung Cancer Trial2M ago
Company AnnouncementsOtsuka’s VOYXACT Phase 3 Data Show Sustained Kidney Function Stabilization in IgA Nephropathy2M ago
Company AnnouncementsOtsuka Lifts 2026 Earnings Outlook and Raises Dividends on Strong Drug Sales3M ago
- Company AnnouncementsOtsuka Holdings Delivers Strong Half-Year Earnings and Lifts 2026 Dividend Forecast3M ago
Pre-EarningsIs OTSKF a Buy, Before Earnings?3M ago
Company AnnouncementsOtsuka Lifts First-Half 2026 Earnings Forecast on Strong Drug Sales and Weak Yen3M ago- Company AnnouncementsOtsuka’s VOYXACT Achieves Key Phase 3 Success in IgA Nephropathy, Bolstering Long-Term Growth Strategy4M ago
Company AnnouncementsOtsuka Holdings Advances Share Buyback, Repurchases ¥29.9 Billion in Stock4M agoCompany AnnouncementsOtsuka’s VOYXACT Shows Kidney Function Preservation in Phase 3 IgA Nephropathy Trial4M ago
Company AnnouncementsOtsuka Advances ¥50 Billion Share Buyback, Repurchasing Over 2 Million Shares5M ago